9PN-33293-10312
2 vaccinations
3 coded responses
22 check-ins
3 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 033 / NH
- Registered
- 2021-09-04
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-09-04
Registered in v-safe
-
2021-09-04
Dose 1 — Pfizer-BioNTech
- 2021-09-04
-
2021-09-05
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain, Redness · Fatigue or tirednessAdult check-in
-
2021-09-06
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain, Redness · HeadacheAdult check-in
- 2021-09-07
- 2021-09-09
- 2021-09-10
- 2021-09-11
- 2021-09-18
-
2021-09-25
Dose 2 — Pfizer-BioNTech
-
2021-09-25
Health check-in — day 0, dose 2Feeling: Fair · Site: Pain · Headache, Muscle or body achesAdult check-in
-
2021-09-26
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-09-27
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Muscle or body achesAdult check-in
- 2021-09-29
- 2021-09-30
- 2021-10-02
- 2021-10-09
- 2021-10-16
- 2021-10-23
-
2021-10-30
Survey response — day 35, dose 2MedDRA: Delivery — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · HospitalizationFree text: I gave birthMedDRA releases: 2024-11 · check-in free text available
-
2021-10-30
Report sent to call center — day 35, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prHospitalization · 1 call case(s)
- 2021-11-02
-
2021-11-04
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
- 2021-11-06
-
2021-12-27
Survey response — 3 months, dose 2MedDRA: Nasopharyngitis — Feeling: GoodFree text: A coldMedDRA releases: 2024-11 · check-in free text available
-
2022-03-26
Survey response — 6 months, dose 2MedDRA: COVID-19, Dyspnoea, Sinusitis — Feeling: Good · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Covid Sinus infection Shortness of breathMedDRA releases: 2024-11 · check-in free text available
-
2022-03-26
Report sent to call center — 6 months, dose 2Be unable to work or attend school · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-03-28
- 2022-09-25
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-09-04 | Pfizer-BioNTech | No |
| 2 | 2021-09-25 | Pfizer-BioNTech | No |
Call center
2 call center cases
1 successful · 1 unsuccessful
Free text
Release 10 — day 35, dose 2
Symptoms: I gave birth
Release 10 — 3 months, dose 2
Symptoms: A cold
Release 11 — 6 months, dose 2
Symptoms: Covid Sinus infection Shortness of breath
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SD | Delivery | · | · | ✓ |
| SD | Dyspnoea | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Sinusitis | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release